Bulgaricus R-1 strain was administered for 12 weeks, and these probiotics significantly increased IgA production in saliva in response to the influenza A H3N2 virus.(15) Strengthening the mucosal barrier with probiotics and prebiotics may increase resistance to viral infections in the host, and future research with this regard is expected. This evidence concerns the gene CD79A and viral infectious disease.